PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search
BNF Chapter
BNF Paragraph
Please select a BNF Chapter.
Search Results : Constipation (Arachis oil - Constipation)
Records returned : 21 (on 01 Sep 2024 at 08:02:58). Return to search results for ' Constipation '.
Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
01.06.03
Green
Formulations :
- Enema
ASPH
RSFT
SASH
SABP
Primary Care
Important
Allergy warning - contains peanut oil
01.06.02
Green
Formulations :
- Capsules
- Oral solution
ASPH
RSFT
SASH
SABP
Primary Care
Green
Formulations :
- Enema
ASPH
RSFT
SASH
SABP
Primary Care
Green
Formulations :
- Sachets (powder)
ASPH
RSFT
SASH
SABP
Primary Care
Important
Prescribe as macrogol compound oral powder sachets
01.06.04
Green
Formulations :
- Oral suspension
ASPH
RSFT
SASH
SABP
Primary Care
01.06.07
Green
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Only after a trial of at least 2 other classes of laxative at the highest recommended, tolerated doses. Consider stopping after 4 weeks if not effective.
01.06.02
Green
Formulations :
- Oral solution
ASPH
RSFT
SASH
SABP
Primary Care
01.04.01
01.06.01
Green
Formulations :
- Sachets (granules)
ASPH
RSFT
SASH
SABP
Primary Care
01.06.02
Green
Formulations :
- Suppositories
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
NOTE - 7.5mg suppositories are non-formulary.
Only the licensed 5mg and 10mg suppositories should be prescribed
01.06.02
Green
Formulations :
- Suppositories
ASPH
RSFT
SASH
SABP
Primary Care
01.06.01
Green
Formulations :
- Sachets (granules)
ASPH
RSFT
SASH
SABP
Primary Care
01.06.04
Green
Formulations :
- Oral solution
ASPH
RSFT
SASH
SABP
Primary Care
01.06.06
Green
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Opioid-induced constipation.
Only after other laxatives have been unsuccessful.
01.06.04
Green
Formulations :
- Enema
ASPH
RSFT
SASH
SABP
Primary Care
Important
Contraindicated in patients with CKD, dehydration and heart failure (among others).
01.06.02
Green
Formulations :
- Liquid
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
01.06.04
Green
Formulations :
- Enema
ASPH
RSFT
SASH
SABP
Primary Care
01.06.02
Green (see narrative)
Formulations :
- Oral suspension
ASPH
RSFT
SASH
SABP
Primary Care
Important
Only for use in end-of-life patients
01.06.02
Green (see narrative)
Formulations :
- Oral suspension
ASPH
RSFT
SASH
SABP
Primary Care
Important
Only for use in end-of-life patients
01.06.06
Green (see narrative)
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Opioid-induced constipation.
Only after other laxatives have been unsuccessful.
01.06.06
Red
Formulations :
- Injection
ASPH
RSFT
SASH
SABP
Primary Care
Important
For opioid-induced constipation in terminally ill patients when response to other laxatives is inadequate
RSCH Palliative Care Team only
01.06.02
Non Formulary
Formulations :
- Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
Important
7.5mg suppositories are unlicensed and not approved for use in Surrey Heartlands.
For information about the icons and status values within this site, please refer to the keys below.
Icon/Links Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq form to be completed
NICE
Traffic Light Status Key
Red
Amber
Green
Black
Amber Star
Green (see narrative)
Non Formulary
See Below
N/A
Blue
Green - Black
See narrative
Do not initiate in new patients